🇺🇸 FDA

Drug profile · INN

evans blue

EVANS BLUE

approved
US status
approved
Patents linked
5
News articles
0

Quick answer

evans blue (EVANS BLUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN evans blue
Brand EVANS BLUE
Route INJECTION
Formulation INJECTABLE

Related patents

Search patents →

  1. US 12161733

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10981866

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10709790

    Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics

    Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10696631

    Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10258701

    Labeled evans blue dye derivative for in vivo serum albumin labeling

    Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is evans blue?

evans blue (EVANS BLUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for evans blue?

EVANS BLUE is a marketed brand name for evans blue. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of evans blue?

evans blue has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.